256 related articles for article (PubMed ID: 31173889)
1. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017.
Tickler IA; Obradovich AE; Goering RV; Fang FC; Tenover FC;
Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889
[TBL] [Abstract][Full Text] [Related]
2. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
4. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
Seo MR; Kim B; Kim J; Pai H
Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
[TBL] [Abstract][Full Text] [Related]
5. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
Piepenbrock E; Stelzer Y; Berger F; Jazmati N
Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
[TBL] [Abstract][Full Text] [Related]
6. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.
Cheknis A; Johnson S; Chesnel L; Petrella L; Sambol S; Dale SE; Nary J; Sears P; Citron DM; Goldstein EJC; Gerding DN
Anaerobe; 2018 Oct; 53():38-42. PubMed ID: 29886050
[TBL] [Abstract][Full Text] [Related]
8. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance for genotyping and resistance testing of Clostridium (Clostridioides) difficile isolates - Experiences from the first inter-laboratory ring trial in four German speaking countries.
Berger FK; Mellmann A; von Müller L; Bischoff M; Gärtner BC;
Anaerobe; 2020 Feb; 61():102093. PubMed ID: 31494260
[TBL] [Abstract][Full Text] [Related]
11. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
[TBL] [Abstract][Full Text] [Related]
13. Microbiological characteristics of human and animal isolates of Clostridioides difficile in Italy: Results of the Istituto Superiore di Sanità in the years 2006-2016.
Barbanti F; Spigaglia P
Anaerobe; 2020 Feb; 61():102136. PubMed ID: 31857201
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019.
Abdrabou AMM; Ul Habib Bajwa Z; Halfmann A; Mellmann A; Nimmesgern A; Margardt L; Bischoff M; von Müller L; Gärtner B; Berger FK
Int J Med Microbiol; 2021 May; 311(4):151507. PubMed ID: 33915347
[TBL] [Abstract][Full Text] [Related]
16. PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.
Karlowsky JA; Adam HJ; Kosowan T; Baxter MR; Nichol KA; Laing NM; Golding G; Zhanel GG
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):105-111. PubMed ID: 29456070
[TBL] [Abstract][Full Text] [Related]
17. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterisation of Clostridium difficile PCR ribotype 251, an emerging multi-locus sequence type clade 2 strain in Australia.
Hong S; Knight DR; Chang B; Carman RJ; Riley TV
Anaerobe; 2019 Dec; 60():102066. PubMed ID: 31260740
[TBL] [Abstract][Full Text] [Related]
19. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
Tratulyte S; Miciuleviciene J; Kuisiene N
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067
[TBL] [Abstract][Full Text] [Related]
20. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
